GIBH-R-001-2

N/A

Report date: 2025/06/11 20:01:15
NME

Base Information

Drug NameGIBH-R-001-2
Drug Alias NameAS-001GIBH-R-001-2
ClassificationSmall molecules > Nucleosides and nucleotide derivtives > Oligonucleotide > Small Interfering RNA
Mechanisms of ActionTumor necrosis factor inhibitorsADAMTS5 inhibitors
TargetsADAMTS5Tumor necrosis factor
Therapy Area/IndicationsOsteoarthritisArthritis, Rheumatoid
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaPending
Originator CompaniesGuangzhou Institute Of Biomedicine And Health, Chinese Academy Of Sciences
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesGuangzhou Institute Of Biomedicine And Health, Chinese Academy Of Sciences
Active IndicationsN/A
Inactive IndicationsOsteoarthritisArthritis, Rheumatoid

Other Information

ATC CodeN/A
Related LinksN/A